Literature DB >> 8541097

A non-invasive test for the pre-cancerous breast.

H W Simpson1, C McArdle, A W Pauson, P Hume, A Turkes, K Griffiths.   

Abstract

This paper describes a non-invasive, self-measured procedure by which the precancerous breast can be distinguished from the normal breast. The method involves wearing a specially designed thermometric brassiere for 90 min each evening at home through one menstrual cycle. Profiles of progesterone through the cycle, obtained from daily saliva sampling, and determination of the steroid content by radioimmunoassay, are made to allow the status and calendar date timing of the luteal phase to be established. Thus, cycles can be synchronised across subjects. In this study, two types of breast were compared: 50 normal breasts and 41 age-matched precancerous breasts. Differences between the groups were striking in terms of amplitude, phasing and average temperature during the luteal heat cycle. When these parameters and others were used as predictors in a linear discrimination and/or neural net analysis, a sensitivity and specificity of > 90% was achieved.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541097     DOI: 10.1016/0959-8049(95)00379-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

Review 1.  Primer on machine learning: utilization of large data set analyses to individualize pain management.

Authors:  Parisa Rashidi; David A Edwards; Patrick J Tighe
Journal:  Curr Opin Anaesthesiol       Date:  2019-10       Impact factor: 2.706

2.  The Chronobra identifies prevailing mammary vascularity as a candidate variable in breast cancer post-operative outcome prediction.

Authors:  Hugh W Simpson; David George; Robert B Sothern; Keith Griffiths
Journal:  Springerplus       Date:  2013-05-24

3.  Pregnancy postponement and childlessness leads to chronic hypervascularity of the breasts and cancer risk.

Authors:  H W Simpson; C S McArdle; W D George; K Griffiths; A Turkes; A W Pauson
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.